Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Dr. Paul Gurbel MD

Director of Cardiovascular Research, Sinai Hospital of Baltimore, Inc.

What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Member of the Healthcare Council

Council Member Biography

Paul Gurbel, MD, is Director of Cardiovascular Research at the Center for Thrombosis Research at Sinai Hospital of Baltimore. Dr. Gurbel has authored over 100 peer-reviewed papers related primarily to coronary thrombosis and interventional cardiology. His particular expertise is in translational platelet physiology research. As a practicing interventionalist in a large private practice, he also is Director of Therapeutics, Research and Technology Development for the Cardiac Catheterization Program at Sinai Hospital. He has served as a consultant for companies such as Genentech, Datascope, Bristol Myers Squibb, Medtronic, and Abbott. Dr. Gurbel holds patents on interventional devices and antithrombotic methods and has presented his research at the American College of Cardiology, American Heart Association, European Society of Cardiology, American Federation for Clinical Research, and International Society on Thrombosis and Haemostasis Meetings. (This is me - Update Profile)


Employment History

1998 - Unspecified
Director of Cardiovascular Research, Sinai Hospital of Baltimore, Inc.

GLG NewsSM Analyses by Paul Gurbel(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Paul Gurbel has not published any GLG News Analyses.

View all GLG News in Healthcare

Leading institutions connect with Paul Gurbel through GLG

GLG Live Meetings with Paul Gurbel(?)

Paul Gurbel has not participated in any GLG Live Meetings.

View all GLG Live Meetings in Healthcare